Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-label, Drug-drug-interaction Study to Determine the Effect of Rucaparib on the Pharmacokinetics of Oral Rosuvastatin (Arm A) and Oral Contraceptives (Ethinylestradiol and Levonorgestrel) (Arm B) in Patients With Advanced Solid Tumors
Conditions
Interventions
Rucaparib
Rosuvastatin
+1 more
Locations
7
Hungary
PRA Magyarország Fázis I-es Klinikai Farmakológiai Vizsgálóhely FMC Dialízis Központ, II. em.
Budapest, Hungary
Wojewódzki Szpital Specjalistyczny w Białej Podlaskiej
Biała Podlaska, Poland
BioVirtus Centrum Medyczne
Józefów, Poland
Ujastek Sp. z o.o. Centrum medyczne
Krakow, Poland
Med Polonia Sp. z o.o.
Poznan, Poland
Zdrowie Kobiety Centrum Leczniczo-Rehabilitacyjne i Medycyny Pracy ATTIS Sp. z o.o., Zakład Onkologii Kobiecej
Warsaw, Poland
Start Date
April 25, 2019
Primary Completion Date
December 6, 2019
Completion Date
June 9, 2021
Last Updated
June 8, 2023
NCT00026884
NCT07169851
NCT07213804
NCT07159659
NCT07191730
NCT07481851
Lead Sponsor
pharmaand GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions